PubMed

A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease.

Haywood C Jr, Beach MC, Lanzkron S, Strouse JJ, Wilson R, Park H, Witkop C, Bass EB, Segal JB.

J Natl Med Assoc. 2009 Oct;101(10):1022-33.PMID: 19860302 [PubMed - in process]Related articles

The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization.

Carroll CP, Haywood C Jr, Fagan P, Lanzkron S.

Am J Hematol. 2009 Oct;84(10):666-70.PMID: 19743465 [PubMed - in process]Related articles

The excess burden of stroke in hospitalized adults with sickle cell disease.

Strouse JJ, Jordan LC, Lanzkron S, Casella JF.

Am J Hematol. 2009 Sep;84(9):548-52.PMID: 19623672 [PubMed - indexed for MEDLINE]Related articles

Health care provider attitudes toward patients with acute vaso-occlusive crisis due to sickle cell disease: development of a scale.

Ratanawongsa N, Haywood C Jr, Bediako SM, Lattimer L, Lanzkron S, Hill PM, Powe NR, Beach MC.

Patient Educ Couns. 2009 Aug;76(2):272-8. Epub 2009 Feb 23.PMID: 19233587 [PubMed - in process]Related articles

Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children.

Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, Wilson RF, Bass EB, Segal JB.

Pediatrics. 2008 Dec;122(6):1332-42. Review.PMID: 19047254 [PubMed - indexed for MEDLINE]Related articles

Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.

Lanzkron S, Haywood C Jr, Hassell KL, Rand C.

J Natl Med Assoc. 2008 Aug;100(8):968-73.PMID: 18717150 [PubMed - indexed for MEDLINE]Related articles

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

Ann Intern Med. 2008 Jun 17;148(12):939-55. Epub 2008 May 5. Review.PMID: 18458272 [PubMed - indexed for MEDLINE]Related articlesFree article

Hydroxyurea for the treatment of sickle cell disease.

Segal JB, Strouse JJ, Beach MC, Haywood C, Witkop C, Park H, Wilson RF, Bass EB, Lanzkron S.

Evid Rep Technol Assess (Full Rep). 2008 Mar;(165):1-95. Review.PMID: 18457478 [PubMed - indexed for MEDLINE]Related articles

NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea.

Liebelt EL, Balk SJ, Faber W, Fisher JW, Hughes CL, Lanzkron SM, Lewis KM, Marchetti F, Mehendale HM, Rogers JM, Shad AT, Skalko RG, Stanek EJ.

Birth Defects Res B Dev Reprod Toxicol. 2007 Aug;80(4):259-366. No abstract available. PMID: 17712860 [PubMed - indexed for MEDLINE]Related articles

Self-perceived loss of control and untreated dental decay in African American adults with and without sickle cell disease.

Laurence B, Woods D, George D, Onyekwere O, Katz R, Lanzkron S, Diener-West M, Powe N.

J Health Care Poor Underserved. 2006 Aug;17(3):641-51.PMID: 16960327 [PubMed - indexed for MEDLINE]Related articles

Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.

Lanzkron S, Haywood C Jr, Segal JB, Dover GJ.

Am J Hematol. 2006 Dec;81(12):927-32.PMID: 16924648 [PubMed - indexed for MEDLINE]Related articles

The association between sickle cell disease and dental caries in African Americans.

Laurence B, George D, Woods D, Shosanya A, Katz RV, Lanzkron S, Diener-West M, Powe N.

Spec Care Dentist. 2006 May-Jun;26(3):95-100.PMID: 16774185 [PubMed - indexed for MEDLINE]Related articlesFree article

High prevalence and correlates of low bone mineral density in young adults with sickle cell disease.

Miller RG, Segal JB, Ashar BH, Leung S, Ahmed S, Siddique S, Rice T, Lanzkron S.

Am J Hematol. 2006 Apr;81(4):236-41.PMID: 16550513 [PubMed - indexed for MEDLINE]Related articles

Polymerized human Hb use in acute chest syndrome: a case report.

Lanzkron S, Moliterno AR, Norris EJ, Gould SA, Segal J, Nuermberger EL, Ness PM.

Transfusion. 2002 Nov;42(11):1422-7.PMID: 12421214 [PubMed - indexed for MEDLINE]Related articles

Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue.

Shaughnessy PJ, Ririe DW, Ornstein DL, Kissack B, Bickford DJ, Molina R, Lanzkron S, Bachier C, Nanez A, LeMaistre CF.

Bone Marrow Transplant. 2001 Jan;27(2):221-4.PMID: 11281396 [PubMed - indexed for MEDLINE]Related articlesFree article

Homing of long-term and short-term engrafting cells in vivo.

Lanzkron SM, Collector MI, Sharkis SJ.

Ann N Y Acad Sci. 1999 Apr 30;872:48-54; discussion 54-6.PMID: 10372110 [PubMed - indexed for MEDLINE]Related articles

Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.

Bachier CR, Gokmen E, Teale J, Lanzkron S, Childs C, Franklin W, Shpall E, Douville J, Weber S, Muller T, Armstrong D, LeMaistre CF.

Exp Hematol. 1999 Apr;27(4):615-23.PMID: 10210319 [PubMed - indexed for MEDLINE]Related articles

Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells.

Lanzkron SM, Collector MI, Sharkis SJ.

Blood. 1999 Mar 15;93(6):1916-21.PMID: 10068664 [PubMed - indexed for MEDLINE]Related articlesFree article

Cytokine induction of platelet activation.

Lumadue JA, Lanzkron SM, Kennedy SD, Kuhl DT, Kickler TS.

Am J Clin Pathol. 1996 Dec;106(6):795-8.PMID: 8980357 [PubMed - indexed for MEDLINE]Related articles